Generic selegiline patch tested against brand in healthy volunteers
NCT ID NCT06607744
First seen Feb 27, 2026 · Last updated May 19, 2026 · Updated 11 times
Summary
This study tested a generic version of the selegiline skin patch against the brand-name EMSAM in 12 healthy adults. The goal was to see how much of the drug gets into the blood and to check for skin irritation or other side effects. The results help show if the generic patch works the same way as the brand.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MDD are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hospital Ampang
Ampang, Selangor, 68000, Malaysia
-
Sarawak General Hospital
Samoran, Sarawak, 94300, Malaysia
Conditions
Explore the condition pages connected to this study.